Andere Sprachen Nkarta, Inc.

Aktien

A2P797

US65487U1088

NKTX

Markt geschlossen - Nasdaq Andere Börsenplätze 22:00:00 30.04.2024			% 5 Tage	% 1. Jan.
6,68 ^USD	-3,47 %		-11,64 %	+1,21 %

26.03.	NKARTA, INC. : Canaccord Genuity bleibt bei seiner Kaufempfehlung	ZM
25.03.	NKARTA, INC. : Bewertung von HC Wainwright zum Kaufen erhalten	ZM

Andere Sprachen

Erhalten Sie Zugang zu allen Nachrichten über alle Unternehmen: Verpassen Sie keine profitable Anlagechance mehr!

100% kostenlose Registrierung

Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Announces Investigation of Nkarta, Inc. (NKTX) on Behalf of Investors	08.04.
Law Offices of Howard G. Smith Announces Investigation of Nkarta, Inc. (NKTX) on Behalf of Investors	05.04.
The Law Offices of Frank R. Cruz Announces Investigation of Nkarta, Inc. (NKTX) on Behalf of Investors	05.04.
Nkarta to Participate in Upcoming Investor Conferences	03.04.
Nkarta Prices $240.1 Million Underwritten Offering	25.03.
Nkarta Announces Pricing of $240 Million Underwritten Offering	25.03.
North American Morning Briefing : Tech in Focus on -2-	25.03.
Nkarta Trims Q4 Loss -- Shares Up After Hours	21.03.
Nkarta Reports Fourth Quarter and Full Year 2023 Financial Results and Corporate Highlights	21.03.
Nkarta, Inc. Reports Earnings Results for the Fourth Quarter Ended December 31, 2023	21.03.
Nkarta to Participate in Upcoming Investor Conferences	28.02.
Nkarta, Inc.(NasdaqGS:NKTX) dropped from NASDAQ Biotechnology Index	15.12.
Nkarta Presents NKX101 Clinical Data at the 2023 American Society of Hematology Annual Meeting & Exposition	10.12.
Nkarta, Inc. Presents NKX101 Clinical Data at the 2023 American Society of Hematology Annual Meeting & Exposition	10.12.
Nkarta, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	09.11.
Nkarta Reports Third Quarter 2023 Financial Results and Corporate Highlights	09.11.
Nkarta to Participate at Upcoming Investor Conferences	07.11.
Lupus Therapeutics Announces Partnership to Support the Evaluation of Natural Killer Cell Therapy in Lupus Nephritis	18.10.23
North American Morning Briefing : Geopolitical -2-	18.10.23
Sector Update: Health Care Stocks Retreat in Late Afternoon	17.10.23

Keine Ergebnisse zu dieser Suche

Alle Nachrichten Analystenempfehlungen Wichtige Fakten Insiders Transkripte Pressemitteilungen Offizielle Publikationen Andere Sprachen Trading-Ideen MarketScreener Artikel MarketScreener Analysen

Andere Sprachen Nkarta, Inc.

Aktien

A2P797

US65487U1088

NKTX

Andere Sprachen

Filter